Barcelona, Sally .
HRN: 26-16-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2024
CEFTRIAXONE 1G (VIAL)
12/01/2024
12/07/2024
IV
2g
Q24
Cholelithiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes